What is the current market valuation of the cell banking-outsourcing market in South America?

The market valuation was $1312.7 Million in 2024. Read More

What is the projected market valuation for the cell banking-outsourcing market by 2035?

The projected valuation for 2035 is $4443.0 Million. Read More

What is the expected CAGR for the cell banking-outsourcing market during the forecast period 2025 - 2035?

The expected CAGR is 11.72% during the forecast period 2025 - 2035. Read More

Which companies are considered key players in the South American cell banking-outsourcing market?

Key players include Thermo Fisher Scientific, Merck KGaA, Lonza Group, and Fujifilm Holdings Corporation. Read More

What are the main segments of the cell banking-outsourcing market?

The main segments include Bank Type, Cell Type, and Application. Read More

What is the valuation range for Stem Cell Banking in the market?

The valuation range for Stem Cell Banking is $200.0 Million to $700.0 Million. Read More

How does the valuation of Cord Stem Cell Banking compare to other segments?

Cord Stem Cell Banking has a valuation range of $300.0 Million to $1000.0 Million, indicating strong market interest. Read More

What applications are included in the cell banking-outsourcing market?

Applications include Cell Bank Storage, Bank Characterization & Testing, and Gene Sequencing Testing. Read More

What is the valuation range for Non-Stem Cell Banking?

The valuation range for Non-Stem Cell Banking is $162.7 Million to $643.0 Million. Read More

How does the market performance of Adult Stem Cell Banking appear in comparison to other cell types?

Adult Stem Cell Banking shows a valuation range of $250.0 Million to $800.0 Million, suggesting robust demand. Read More

South America Cell Banking Outsourcing Market

ID: MRFR/LS/49577-HCR

200 Pages

Satyendra Maurya

Last Updated: February 06, 2026

South America Cell Banking Outsourcing Market Research Report By Bank Type (Master Cell Banking, Working Cell Banking, Viral Cell Banking), By Cell Type (Stem Cell Banking, Cord Stem Cell Banking, Embryonic Stem Cell Banking, Adult Stem Cell Banking, Dental Stem Cell Banking, IPS Stem Cell Banking, Non-Stem Cell Banking), By Application (Cell Bank Storage, Master Cell Bank Storage, Working Cell Bank Storage, Cell Storage Stability Testing, Cell Bank Preparation, Master Cell Bank Preparation, Working Cell Bank Preparation, Bank Characterization & Testing, Viral Cell Bank Safety Testing, Microbial Cell Bank Safety Testing, Gene Expression Testing, Karyology Testing, Gene Sequencing Testing) and By Regional (Brazil, Mexico, Argentina, Rest of South America) - Growth & Industry Forecast 2025 To 2035

South America Cell Banking Outsourcing Market Infographic

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Life Sciences, BY Bank Type (USD Million)
  1. 4.1.1 Master Cell Banking
  2. 4.1.2 Working Cell Banking
  3. 4.1.3 Viral Cell Banking
2. 4.2 Life Sciences, BY Cell Type (USD Million)
  1. 4.2.1 Stem Cell Banking
  2. 4.2.2 Cord Stem Cell Banking
  3. 4.2.3 Embryonic Stem Cell Banking
  4. 4.2.4 Adult Stem Cell Banking
  5. 4.2.5 Dental Stem Cell Banking
  6. 4.2.6 IPS Stem Cell Banking
  7. 4.2.7 Non-Stem Cell Banking
3. 4.3 Life Sciences, BY Application (USD Million)
  1. 4.3.1 Cell Bank Storage
  2. 4.3.2 Cell Bank Preparation
  3. 4.3.3 Bank Characterization & Testing
  4. 4.3.4 Viral Cell Bank Safety Testing
  5. 4.3.5 Microbial Cell Bank Safety Testing
  6. 4.3.6 Gene Expression Testing
  7. 4.3.7 Karyology Testing
  8. 4.3.8 Gene Sequencing Testing
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Life Sciences
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Life Sciences
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Thermo Fisher Scientific (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Merck KGaA (DE)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Lonza Group (CH)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Fujifilm Holdings Corporation (JP)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Celerion (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Cryoport, Inc. (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 BioLife Sciences (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Cell and Gene Therapy Catapult (GB)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 SOUTH AMERICA MARKET ANALYSIS BY BANK TYPE
3. 6.3 SOUTH AMERICA MARKET ANALYSIS BY CELL TYPE
4. 6.4 SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
5. 6.5 KEY BUYING CRITERIA OF LIFE SCIENCES
6. 6.6 RESEARCH PROCESS OF MRFR
7. 6.7 DRO ANALYSIS OF LIFE SCIENCES
8. 6.8 DRIVERS IMPACT ANALYSIS: LIFE SCIENCES
9. 6.9 RESTRAINTS IMPACT ANALYSIS: LIFE SCIENCES
10. 6.10 SUPPLY / VALUE CHAIN: LIFE SCIENCES
11. 6.11 LIFE SCIENCES, BY BANK TYPE, 2024 (% SHARE)
12. 6.12 LIFE SCIENCES, BY BANK TYPE, 2024 TO 2035 (USD Million)
13. 6.13 LIFE SCIENCES, BY CELL TYPE, 2024 (% SHARE)
14. 6.14 LIFE SCIENCES, BY CELL TYPE, 2024 TO 2035 (USD Million)
15. 6.15 LIFE SCIENCES, BY APPLICATION, 2024 (% SHARE)
16. 6.16 LIFE SCIENCES, BY APPLICATION, 2024 TO 2035 (USD Million)
17. 6.17 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY BANK TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY CELL TYPE, 2025-2035 (USD Million)
  3. 7.2.3 BY APPLICATION, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

South America Life Sciences Market Segmentation

Life Sciences By Bank Type (USD Million, 2025-2035)

Master Cell Banking
Working Cell Banking
Viral Cell Banking

Life Sciences By Cell Type (USD Million, 2025-2035)

Stem Cell Banking
Cord Stem Cell Banking
Embryonic Stem Cell Banking
Adult Stem Cell Banking
Dental Stem Cell Banking
IPS Stem Cell Banking
Non-Stem Cell Banking

Life Sciences By Application (USD Million, 2025-2035)

Cell Bank Storage
Cell Bank Preparation
Bank Characterization & Testing
Viral Cell Bank Safety Testing
Microbial Cell Bank Safety Testing
Gene Expression Testing
Karyology Testing
Gene Sequencing Testing

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”